52150IDR
187.70 BIDR
2.75 TIDR
About ORGANON PHARMA INDONESIA TBK
Sector
CEO
Daniel
Headquarters
Jakarta
Website
Employees (FY)
199
Founded
1972
ISIN
ID1000088800
FIGI
BBG000BFS6C6
PT Organon Pharma Indonesia Tbk engages in the development, manufacture, and distribution of pharmaceutical products. It operates through the Pharmaceutical Manufacturing and Commercial segments. The company was founded on March 7, 1972 and is headquartered in Jakarta, Indonesia.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of SCPI is 29000 IDR — it hasn't changed in the past 24 hours. Watch ORGANON PHARMA INDONESIA TBK stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on IDX exchange ORGANON PHARMA INDONESIA TBK stocks are traded under the ticker SCPI.
Yes, you can track ORGANON PHARMA INDONESIA TBK financials in yearly and quarterly reports right on TradingView.
SCPI net income for the last quarter is −73.82 B IDR, while the quarter before that showed 126.79 B IDR of net income which accounts for −158.22% change. Track more ORGANON PHARMA INDONESIA TBK financial stats to get the full picture.
Like other stocks, SCPI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ORGANON PHARMA INDONESIA TBK stock right from TradingView charts — choose your broker and connect to your account.
SCPI reached its all-time high on Oct 28, 2010 with the price of 43000 IDR, and its all-time low was 7800 IDR and was reached on Nov 29, 2006. View more price dynamics on SCPI chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
As of May 6, 2024, the company has 199.00 employees. See our rating of the largest employees — is ORGANON PHARMA INDONESIA TBK on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ORGANON PHARMA INDONESIA TBK technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ORGANON PHARMA INDONESIA TBK stock shows the sell signal. See more of ORGANON PHARMA INDONESIA TBK technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ORGANON PHARMA INDONESIA TBK EBITDA is 277.57 B IDR, and current EBITDA margin is 10.10%. See more stats in ORGANON PHARMA INDONESIA TBK financial statements.